Download Medical Notes on 2019 R&D Achievements New product launches, clinical trial activity, and investments

2019 R&D Achievements New product launches, clinical trial activity, and investments Medical Notes

About This Presentation

Description:This report titled, “Innovation in Diabetes Care Technology” is by the IQVIA Institute and assesses the current status in the R&D of medicines, especially coronavirus COVID-19 pandemic outbreak. The report provides an analysis of the number of initiated clinical trials and insight into the success rate of products after development. The current state of innovation is explored by examining the record numbers of new active substances (NAS) launched in 2019, analyzing their features and development path, as well as the important contributions of both NAS and non-NAS therapies. The levels of life science venture capital activity and large pharma R&D spend grew. This report also details the expanding pipeline of therapies still under development, examines trends among therapy areas, and analyzes the growing number of Next- Generation Biotherapeutic products, which include cell, gene, and nuc

Tags:COVID-19, pandemic, clinical trials, new product development, pharma R and D, pharma pharmaceutical

Published on: Jul 20, 2020 | Views : 1270 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Market shifts and digital revolution in Healthcare

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

Market shifts and digital revolution in Healthcare

Global Oncology Trends 2019 - Therapeutics, Clinical Development and Health System Implications

Fight to Reduce Cancer Mortality

In Search of the Perfect Health System

IP in Life Sciences – Digital Health Solution

Understanding Neuromuscular Disease Care Current State and Future Prospects

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

Electrolyte Disorders

Pharmacy Handbook to Compliance

HEALTH A TO Z